The analysis originates from neoepitope prediction based on the patient’s tumor sequencing data. A tumor sample is obtained by a biopsy. From there, genes and variants expressed in the patient’s tumor sample are selected and further optimized to produce a stable and efficient peptide. The sequences that correspond to peptides that would b
The analysis originates from neoepitope prediction based on the patient’s tumor sequencing data. A tumor sample is obtained by a biopsy. From there, genes and variants expressed in the patient’s tumor sample are selected and further optimized to produce a stable and efficient peptide. The sequences that correspond to peptides that would best bind to different HLA class I and II molecules are prioritized for synthesis.
The VEGFR vaccine is a peptide-based vaccine with a singular purpose, to help the immune system identify markers specific to blood vessels that feed tumors.
While it is an off-the-shelf product, the peptides used in the production of this vaccine are found in around 98% of all tumor-related blood vessels, making it an efficient way to help
The VEGFR vaccine is a peptide-based vaccine with a singular purpose, to help the immune system identify markers specific to blood vessels that feed tumors.
While it is an off-the-shelf product, the peptides used in the production of this vaccine are found in around 98% of all tumor-related blood vessels, making it an efficient way to help diminish blood flow, and inhibiting a tumor’s ability to protect itself from the immune system.
In cutting off a tumor’s blood supply, it will undergo oxidative stress and become more susceptible to attack by the immune system due to its weakened state.
Are considered to be gatekeepers of the immune response. In cancer patients DC are “programmed” by the tumor to remain in an immature state. This allows the tumor to grow without the immune response killing it. In our treatment protocol we generate DC´s from the patient, activate them to mature in the lab, and subsequently re-administe
Are considered to be gatekeepers of the immune response. In cancer patients DC are “programmed” by the tumor to remain in an immature state. This allows the tumor to grow without the immune response killing it. In our treatment protocol we generate DC´s from the patient, activate them to mature in the lab, and subsequently re-administer them. This stimulates the immune system to begin attacking the cancer.
This proprietary placenta derived vaccine affords us the ability to train the immune system to recognize and selectively destroy tumor blood vessels exclusively. This is a second generation vaccine that has undergone rigorous clinical testing and has shown to be effective in a variety of solid tumor applications.
Natural Killer cells have a unique and critically important role in fighting pathogens. NK cells are a key component of the innate immune system and are responsible for a selective and rapid attack on tumor cells. NK cells, through a sequence of subsequent immune stimulatory activity, also have the power to awaken the adaptive immune syst
Natural Killer cells have a unique and critically important role in fighting pathogens. NK cells are a key component of the innate immune system and are responsible for a selective and rapid attack on tumor cells. NK cells, through a sequence of subsequent immune stimulatory activity, also have the power to awaken the adaptive immune system, thereby producing a powerful, multi-factorial immune response against its target.
Is a small molecule peptide that was demonstrated to stimulate DC in the body. This immune activator was used for over 20 years as an “adjuvant” to numerous vaccines in order to stimulate cell mediated immunity. The utilization of NanoStilbene in combination with our DC protocol ensures that the cells remain in an activated state, which allows them to elicit maximal anti-tumor response.
Is administered as a direct anticancer agent. Studies have shown that plasma concentrations of vitamin C achievable only by intravenous administration cause generation of localized hydrogen peroxide, which causes selective killing of tumor cells but spares non-malignant cells.